Document Detail


Functional characterization of a partial loss-of-function mutation of the epithelial sodium channel (ENaC) associated with atypical cystic fibrosis.
MedLine Citation:
PMID:  20054153     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Loss-of-function mutations of the epithelial sodium channel (ENaC) may contribute to pulmonary symptoms resembling those of patients with atypical cystic fibrosis (CF). Recently, we identified a loss-of-function mutation in the alpha-subunit of ENaC (alphaF61L) in an atypical CF patient without mutations in CFTR. To investigate the functional effect of this mutation, we expressed human wild-type alpha beta gamma-ENaC or mutant alpha(F61L) beta gamma-ENaC in Xenopus laevis oocytes. The alphaF61L mutation reduced the ENaC mediated whole-cell currents by approximately 90%. In contrast, the mutation decreased channel surface expression only by approximately 40% and did not alter the single-channel conductance. These findings indicate that the major effect of the mutation is a reduction of the average channel open probability (P(o)). This was confirmed by experiments using the betaS520C mutant ENaC which can be converted to a channel with a P(o) of nearly one, and by experiments using chymotrypsin to proteolytically activate the channel. These experiments revealed that the mutation reduced the average P(o) of ENaC by approximately 75%. Na(+) self inhibition of the mutant channel was significantly enhanced, but the observed effect was too small to account for the large reduction in average channel P(o). The ENaC-activator S3969 partially rescued the loss-of-function phenotype of the alphaF61L mutation. We conclude that the alphaF61L mutation may contribute to respiratory symptoms in atypical CF patients.
Authors:
Regina Huber; Bettina Krueger; Alexei Diakov; Judit Korbmacher; Silke Haerteis; J?rgen Einsiedel; Peter Gmeiner; Abul Kalam Azad; Harry Cuppens; Jean-Jaques Cassiman; Christoph Korbmacher; Robert Rauh
Related Documents :
20980393 - Specific phosphorylation of ser458 of a-type lamins in lmna-associated myopathy patients.
12467733 - Early and severe presentation of x-linked myotubular myopathy in a girl with skewed x-i...
22355013 - Phylogeny of shiga toxin-producing escherichia coli o157 isolated from cattle and clini...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2009-12-22
Journal Detail:
Title:  Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology     Volume:  25     ISSN:  1421-9778     ISO Abbreviation:  Cell. Physiol. Biochem.     Publication Date:  2010  
Date Detail:
Created Date:  2010-01-07     Completed Date:  2010-02-25     Revised Date:  2010-04-15    
Medline Journal Info:
Nlm Unique ID:  9113221     Medline TA:  Cell Physiol Biochem     Country:  Switzerland    
Other Details:
Languages:  eng     Pagination:  145-58     Citation Subset:  IM    
Copyright Information:
2010 S. Karger AG, Basel
Affiliation:
Institut f?r Zellul?re und Molekulare Physiologie, Erlangen, Germany.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Chymotrypsin / metabolism
Cystic Fibrosis / genetics*,  metabolism
Epithelial Sodium Channel / analysis,  genetics*,  metabolism*
Female
Gene Expression
Humans
Mutation*
Oocytes / metabolism
Sodium / metabolism
Xenopus laevis
Chemical
Reg. No./Substance:
0/Epithelial Sodium Channel; 7440-23-5/Sodium; EC 3.4.21.1/Chymotrypsin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Differential effects of hypoxic stress in alveolar epithelial cells and microvascular endothelial ce...
Next Document:  Characterisation of cadmium chloride induced molecular and functional alterations in airway epitheli...